Category: esters-buliding-blocks

On July 2, 2021, Kabes, Connor; Lucas, Reagan; Gunn, Jack; Gladysz, John published an article.Computed Properties of 10472-24-9 The title of the article was Chiral Cobalt(III) Tris(1,2-diamine) Catalysts That Incorporate Nitrogenous Base Containing Anions for the Bifunctional Activation of Nucleophiles and Electrophiles in Enantioselective Addition Reactions. And the article contained the following:

Here, The lipophilic diastereomeric cobalt complexes Λ or Δ-[Co((S,S)-dpen)3]3+ 2Cl-BArf- (Λ or Δ-(S,S)-23+ 2Cl-BArf-; dpen/BArf- = 1,2-diphenylethylenediamine/B(3,5-C6H3(CF3)2)4-) ,salts of nicotinates, isonicotinates, related sulfonates, and N,N-dimethylaminobenzoate were applied addition reactions. The 6-chloronicotinate salt gaves slower rates and lower ee values, and the 6-aminonicotinate salt gave faster rates and higher ee values. The 6-Me, 2-methoxy, and unsubstituted analogs afforded intermediate results. The 6-aminonicotinate catalyst was applied to additions of di-Me malonate to aryl-substituted nitroolefins and additions of 1,3-dicarbonyl compounds to di-t-Bu azodicarboxylate, with average yields/ee values of 90%/85% and 94%/77%, resp. The authors were unaware of other ionic catalysts for which Bronsted bases was productively incorporated into the anions, which were seldom if ever purposefully functionalized in any manner. The experimental process involved the reaction of Methyl 2-cyclopentanonecarboxylate(cas: 10472-24-9).Computed Properties of 10472-24-9

The Article related to chiral diamine cobalt complex preparation, nitroolefin dimethyl malonate cobalt complex catalyst enantioselective michael addition, ditertiarybutyl azodicarboxylate dicarbonyl compound cobalt catalyst enantioselective michael addition, bistertiarybutoxycarbonyl hydrazino dicarbonyl compound preparation and other aspects.Computed Properties of 10472-24-9

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Luecke, Daniel; Kalesse, Markus published an article in 2019, the title of the article was Polyoxygenated Tertiary Alcohols: A Kiyooka Approach.Recommanded Product: 3976-69-0 And the article contains the following content:

A Kiyooka aldol approach for the stereoselective synthesis of tertiary alcs. I (R = (2R)-3-[(4-methoxyphenyl)methoxy]-2-methylpropyl, (2R)-2-[(4-methoxyphenyl)methoxy]propyl, (2S,3R)-3-[(4-methoxyphenyl)methoxy]-2-methylbutyl, (2R,3R)-3-[(4-methoxyphenyl)methoxy]-2-methylbutyl; R1 = C(O), CH-OTBS) is presented. This approach allows for the incorporation of different substituents at all three remaining positions at the chiral center bearing the tertiary alc.I. To demonstrate the validity of this approach different chiral alcs. I were depicted and the relationship of double bond geometry of the ketene acetal II and the diastereoselectivity was established. The experimental process involved the reaction of (R)-Methyl 3-hydroxybutanoate(cas: 3976-69-0).Recommanded Product: 3976-69-0

The Article related to tertiary alc preparation enantioselective diastereoselective, tertbutyldimethylsilyl protected hemiacetal preparation enantioselective diastereoselective, chiral aldehyde ketene acetal kiyooka aldol reaction, aldol reaction, chiral aldehydes, double bond geometry, ketene acetal, structure elucidation and other aspects.Recommanded Product: 3976-69-0

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On March 20, 2003, Shimano, Masanao; Kamei, Noriyuki; Tanaka, Tomohiro; Harada, Tatsuhiro; Haino, Makoto; Okuyama, Akihiko; Arakawa, Yoshio; Murakami, Yoshiko published a patent.Computed Properties of 37480-41-4 The title of the patent was Preparation of reverse hydroxamic acid derivatives as selective inhibitors of TNF-α converting enzyme (TACE). And the patent contained the following:

Reverse hydroxamic acid derivatives, i.e. N-[2-[[(hetero)arylalkoxy](hetero)arylsulfonyl]ethyl] hydroxamic acid derivatives having specific structures represented by the general formula A-CON(OH)C(R1)(R2a)CH2SO2-Ar1-OCH2Ar2 [A = H, lower alkyl, cycloalkyl, (un)substituted NH2; Ar1 = arylene or heteroarylene; Ar2 = (un)substituted aryl, aralkyl, heteroaryl, or heteroarylalkyl; R1 = H, (un)substituted lower alkyl, lower alkenyl, or cycloalkyl; R2a = Q, Q1; wherein R5, R6, R16 = H, halo, OH, cyano, CF3, (un)substituted lower alkyl or alkoxy; R17 = H, halo, (un)substituted lower alkyl; R68, R69, R70, R71 = H, (un)substituted lower alkyl; X1, X2, Y1, Y2 = a single bond, O, S, (un)substituted CH2 or NH; Z1, Z2 = O, S, (un)substituted :CH or :NH, O(CH2)rO, S(CH2)r1S, O(CH2)t1S; wherein r, r1, t1 = an integer of 2-4; m1, m2 = an integer of 0-6; n1, n2, q1, q2 = an integer of 0-3; p1, p2 = 0, 1] are prepared These compounds are useful for the treatment of diseases caused by TNF-α. Thus, 4-(4-methanesulfonylphenoxymethyl)-2-methylquinoline was treated with lithium diisopropylamide/hexane-heptane-ethylbenzene in THF at -78° for 30 min, treated dropwise with a solution of (tetrahydro-4-ylidene)acetaldehyde in THF, and stirred for 30 min to give 77% 1-[4-(2-methylquinolin-4-ylmethoxy)benzenesulfonyl]-3-(tetrahydropyran-4-ylidene)propan-2-ol (I). To a solution of I and Et3N in CH2Cl2 was added methanesulfonyl chloride at -10° and stirred at room temperature for 12 h to give 100% 2-methyl-4-[4-[3-(tetrahydropyran-4-ylidene)prop-1-en-1-ylsulfonyl]phenoxymethyl]quinoline which was stirred with hydroxylamine in aqueous THF at room temperature for 64 h and then formylated by a mixture of formic acid and acetic anhydride at room temperature for 1 h to give 27.0% N-hydroxy-N-[2-[4-(2-methylquinolin-4-ylmethoxy)benzenesulfonyl]-1-(tetrahydropyran-4-ylidene)ethyl]formamide (II). II and optically active II showed IC50 of 3.5 and 2.2 μM, resp., against TACE and were inactive against MMP1, 2, 3, 8, 9, 13, 14, and 17. II at 3 mg/kg (s.c. injection) in vivo inhibited the Escherichia coli-derived lipopolysaccharide (LPS)-induced production of TNF-α by 74.8% in male Lewis rats. The experimental process involved the reaction of Methyl 1-methyl-4-oxocyclohexanecarboxylate(cas: 37480-41-4).Computed Properties of 37480-41-4

The Article related to reverse hydroxamic acid preparation selective tnf converting enzyme inhibitor, tace selective inhibitor reverse hydroxamic acid preparation, tnf production inhibitor hydroxyquinolinylmethoxybenzenesulfonylethylformamide preparation, hydroxyformamide reverse hydroxamic acid preparation tace inhibitor and other aspects.Computed Properties of 37480-41-4

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On June 15, 2015, Duss, Michael; Capolicchio, Samanta; Linden, Anthony; Ahmed, Nisar; Jessen, Henning J. published an article.Application of 707-07-3 The title of the article was Desymmetrization of myo-inositol derivatives by lanthanide catalyzed phosphitylation with C2-symmetric phosphites. And the article contained the following:

Desymmetrization by phosphorylation represents a promising method with potential impact in many different areas of research. C2-Sym. phosphoramidites have been used to desymmetrize myo-inositol derivatives by functionalization at different positions. With this method, 1:1 mixtures of diastereomers are obtained that can be separated subsequently. In this work, activation of a C2-sym. phosphoramidite is achieved by addition of pentafluorophenol (PFP) and leads to a reactive PFP phosphite, which can then be coupled to protected myo-inositol derivatives with reactive OH groups at the 1, 3, 4 and 6 positions. This strategy enhances the diastereoselectivity of the coupling reaction with a preference towards phosphitylation at position 6 (up to 3:1) or position 3 (up to 2:1). The concept of activation of phosphoramidites via in situ generated pentafluorophenol phosphite triesters is thus proven in these studies. It is further shown that Lewis-Acid catalysis enhances the rate of phosphite triester coupling without affecting the diastereoselectivity. This novel strategy improves access to different phosphorylated myo-inositol derivatives and will thus enable further studies into the function of these important intracellular second messengers. The experimental process involved the reaction of (Trimethoxymethyl)benzene(cas: 707-07-3).Application of 707-07-3

The Article related to pentafluorophenol coupling phosphoramidite pentafluorophenol catalysis inositol intracellular messenger, inositol desymmetrization lanthanide catalyzed phosphitylation phosphorylation phosphoramidite cyclitol, chiral auxiliary, diphosphoinositol polyphosphates, inositol, phosphite, phosphorylation and other aspects.Application of 707-07-3

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On October 1, 2018, Akcha, Selma; Gomez-Ruiz, Santiago; Kellou-Tairi, Safia; Lezama, Luis; Perez, Frank Blanco; Benali-Baitich, Ouassini published an article.Safety of 3-Acetyldihydrofuran-2(3H)-one The title of the article was Synthesis, characterization, solution equilibria, DFT study, DNA binding affinity and cytotoxic properties of a cobalt(II) complex with a 5-pyrazolone ligand. And the article contained the following:

The authors’ work describes the synthesis, the complexation and the characterization of a cobalt(II) complex with a 5-pyrazolone ligand carrying a thioamide group on N1 position. The study of the complexation in solution allowed the determination of the stability constants of the complex and the distribution of the species involving Co(II) over the whole pH-range. The solid cobalt(II) complex has then been synthesized and fully characterized by IR, electronic, EPR and mass spectrometries, in addition to magnetic and voltammetric measurements. The data clearly indicated an octahedral high spin Co(II) complex with two mononeg. mols. of the N,S-ligand, and two water mols., likely in a cis position because of the high anisotropy. DFT calculations performed on both the ligand and the complex structures allowed the authors to study the spectral features, and to propose the most fitting structures to the exptl. data. The interaction of the 5-pyrazolone ligand and its cobalt(II) complex with fish-sperm DNA has been studied by electronic spectrometry and cyclovoltammetry. Intercalation has been identified as a binding mode and the strength of the binding assessed. In order to explore eventual cytotoxic and/or cytostatic properties of the authors’ compounds, the ligand and the cobalt complex have been tested on PC-3 (human prostate carcinoma) and HT-29 (human colon carcinoma) using sulforhodamine B (SRB) assay. The experimental process involved the reaction of 3-Acetyldihydrofuran-2(3H)-one(cas: 517-23-7).Safety of 3-Acetyldihydrofuran-2(3H)-one

The Article related to cobalt carbothioamidepyrazolone aqua complex preparation formation constant, magnetic property optimized mol structure cobalt carbothioamidepyrazolone aqua complex, electrochem dna binding cobalt carbothioamidepyrazolone aqua complex, antitumor activity cobalt carbothioamidepyrazolone aqua complex and other aspects.Safety of 3-Acetyldihydrofuran-2(3H)-one

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On November 12, 2009, Rogers, Kathryn; Patzke, Holger published a patent.Reference of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate The title of the patent was Preparation of benzo-fused 7-membered heterocyclic compounds and methods for treating cognitive disorders using inhibitors of histone deacetylase. And the patent contained the following:

This disclosure relates to compounds for the inhibition of histone deacetylase and treatment of a cognitive disorder or deficit, more specifically neurodegenerative disease, polyglutamine disease, tauopathy, Alzheimer’s Disease, or Huntington’s Disease. More particularly, the disclosure provides for compounds of formula [I; Z = H, (un)substituted NHOH; L = a covalent bond, (un)substituted N(OH); when L = (un)substituted N(OH), Z = H; when Z = H, L = (un)substituted N(OH); J = a covalent bond, :CH, -C1-8 alkyl-, -C0-3 alkyl-C1-5 heteroalkyl-C0-3 alkyl-, -C0-3 alkyl-C2-5 alkenyl-C0-3 alkyl-, -C0-3 alkyl-C2-5 alkynyl-C0-3 alkyl-, -C0-6 alkylaryl-C0-6 alkyl-, -C0-6 alkylaryl-C2-6 heteroalkyl-, etc.; Q = heterocycle-containing group, a covalent bond, -C1-8 alkyl-, -C1-5 alkyl-, -C1-5 heterocyclyl-, ;N-O-, N-(un)substituted -C0-6 alkyl-NH-C0-3 alkyl-, -C0-6 alkyl-O-C0-3 alkyl-, etc.; ring B = 7-membered fused heterocycle group, etc.] or a pharmaceutically acceptable salts thereof. Thus, to a solution of (E)-1-chlorodibenzo[b,f][1,4]oxazepine (229 mg, 1.00 mmol) in DME (3 mL) was added 4-methoxycarbonylphenylboronic acid (216 mg), Pd(PPh3)4 (0.065 mg) and 2 N Na2CO3 (aqueous) (1.5 mL). The reaction mixture was stirred for 2 h at 90° to give, after workup and silica gel chromatog., (Z)-Me 4-(dibenzo[b,f][1,4]oxazepin-1-yl)benzoate (II) (327 mg, 99%) as a yellow foam. To a stirring solution of ester II (327 mg) in MeOH (4.0 mL) and THF (4.0 mL) was added 50% hydroxylamine (aqueous) (1.2 mL, excess) followed by KOH (212 mg) and the reaction mixture was stirred at room temperature for 15 min to give, after workup and silica gel chromatog., (Z)-4-(dibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide (III). III showed IC50 of ≤0.05 μM against histone deacetylase and also IC50 of ≤1 μM for whole-cell histone deacetylase (HDAC) Inhibition assay in primary mouse cortical cultures. The experimental process involved the reaction of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate(cas: 227940-70-7).Reference of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate

The Article related to benzo fused 7 membered heterocycle preparation histone deacetylase inhibitor, neurodegenerative disease polyglutamine disease treatment heterocycle preparation, tauopathy alzheimer disease huntington disease treatment heterocycle preparation, dibenzooxazepine benzopyridooxazepine dibenzothiazepine and other aspects.Reference of tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On April 2, 1999, Akazome, Motohiro; Takahashi, Toshiaki; Ogura, Katsuyuki published an article.Formula: C7H14O3 The title of the article was Enantiomeric Inclusion of α-Hydroxy Esters by (R)-(1-Naphthyl)glycyl-(R)-phenylglycine and the Crystal Structures of the Inclusion Cavities. And the article contained the following:

A simple dipeptide, (R)-(1-naphthyl)glycyl-(R)-phenylglycine [(R,R)-I], formed inclusion compounds with several α-hydroxy esters with high enantioselectivity. By crystallization of a mixture of the dipeptide I and racemic MeCH(OH)CO2Me [(RS)-II] from methanol, asym. recognition occurred to give an inclusion compound that contains S-II in 89% ee. X-ray crystallog. study of the inclusion compound elucidated that the dipeptide mols. arrange in a “folded antiparallel” β-sheetlike structure to accommodate the α-hydroxy ester in the pocket-type cavity surrounded by naphthyl and Ph groups on the sheet. Similarly, MeCH(OH)CO2Et and dihydro-3-hydroxy-4,4-dimethyl-2(3H)-furanone were included with high enantioselectivity of the S form. When bulkier Me3CCH(OH)CO2Me was used as a guest mol., the arrangement of dipeptide mols. changed to an “extended antiparallel” mode, where the naphthyl and Ph groups arranged in a “parallel stacked and displaced” mode and a channel-type cavity was constructed. The guest mols. were accommodated via hydrogen bonding in the channel-type cavity with high enantioselectivity of the S form (82% ee). In the case of Me2CHCH(OH)CO2Me [(RS)-III], optically pure (S)-III formed the dipeptide sheet with the “folded antiparallel” structure by cocrystn. with I, while the “extended antiparallel” structure appeared in the inclusion of (RS)-III. The experimental process involved the reaction of Methyl 2-hydroxy-3,3-dimethylbutanoate(cas: 121129-31-5).Formula: C7H14O3

The Article related to enantioselective inclusion hydroxy ester naphthylglycylphenylglycine, stereoselective crystallization hydroxy ester naphthylglycylphenylglycine, crystal structure hydroxy ester naphthylglycylphenylglycine inclusion complex, hydrogen bond hydroxy ester naphthylglycylphenylglycine inclusion complex and other aspects.Formula: C7H14O3

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Wu, Binyu; Wen, Xiaolu; Chen, Hongbing; Hu, Lin published an article in 2021, the title of the article was N-Nosyl-O-bromoethyl hydroxylamine acts as a multifunctional formaldehyde, formaldimine, and 1,2-oxazetidine surrogate for C-C and C-O bond-forming reactions.Application of 10472-24-9 And the article contains the following content:

N-Nosyl-O-bromoethyl hydroxylamine, a bench stable solid, could function as a novel formaldehyde, formaldimine and 1,2-oxazetidine surrogate under DBU basic conditions were described. By merely using this simple reagent, a broad range of synthetically useful β-aminomethyl ketones I [R1 = Me, Ph, 2-furyl, etc.; R2 = Me, Et, allyl, Bn; R1R2 = (CH2)3, (CH2)4, (CH2)5, etc.; R3 = Ac, CO2Me, CO2Et, SO2Ph] and α-hydroxymethyl ketones II [R4 = Me, Et, allyl, Bn; Q = (CH2)n, n = 1,2], as well as chiral α-alkoxyl indanone carboxylates III [R5 = H, 4-MeO, 5-F, etc.; X = OCH2CH2] and α-aminomethyl indanone carboxylates III [X = CH2] could be divergently obtained via chemo- and stereoselective aldol, Mannich or umpolung C-O bond-forming reactions. The challenging catalytic asym. Mannich reaction of formaldimine equivalent was also realized with moderate enantioselectivities. The experimental process involved the reaction of Methyl 2-cyclopentanonecarboxylate(cas: 10472-24-9).Application of 10472-24-9

The Article related to aminomethyl ketone preparation, nosyl bromoethyl hydroxylamine benzoyl acetate bond formation, hydroxymethyl ketone preparation, hydroxy ketone nosyl bromoethyl hydroxylamine bond formation, carboxylate indanone hydroxymethyl preparation enantioselective chemoselective, alkoxyl indanone carboxylate preparation enantioselective chemoselective and other aspects.Application of 10472-24-9

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On June 10, 2004, Fujimoto, Roger Aki; McQuire, Leslie Wighton; Monovich, Lauren G.; Mugrage, Benjamin Biro; Parker, David Thomas; Van Duzer, John Henry; Wattanasin, Sompong published a patent.Formula: C12H14F3NO2 The title of the patent was Preparation of substituted amino phenylacetic acids and derivatives and their use as cyclooxygenase-2 (COX-2) inhibitors. And the patent contained the following:

The title compounds I (R = H, alkyl, cycloalkyl, halo, alkoxy, F3CO, Me3C, cyano, R1 = biaryl, β-naphthyl derivative, bicyclic heterocyclic aryl, cycloalkyl monocyclic carbocyclic aryl, cycloalkane fused-monocyclic carbocyclic aryl) were prepared Thus, N,N-dimethyl-2-(2′,3′,5′,6′-tetrafluoro-4′-phenylanilino)phenylacetamide was hydrolyzed to give I (R = H, R1 = 4-PhC6F4). The experimental process involved the reaction of tert-Butyl (4-(trifluoromethyl)phenyl)carbamate(cas: 141940-37-6).Formula: C12H14F3NO2

The Article related to phenylacetic acid amino preparation cyclooxygenase 2 inhibitor, rheumatoid arthritis inhibitor aminophenylacetic acid, osteoarthritis inhibitor aminophenylacetic acid, dysmenorrhea inhibitor aminoophenylacetic acid, pain inhibitor aminophenylacetic acid, neoplasm inhibitor aminophenylacetic acid, inflammation inhibitor aminophenylacetic acid and other aspects.Formula: C12H14F3NO2

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Burghart-Stoll, Heike; Brueckner, Reinhard published an article in 2012, the title of the article was Total Syntheses of the Gregatins A-D and Aspertetronin A: Structure Revisions of These Compounds and of Aspertetronin B, Together with Plausible Structure Revisions of Gregatin E, Cyclogregatin, Graminin A, the Penicilliols A and B, and the Huaspenones A and B.Category: esters-buliding-blocks And the article contains the following content:

Comprehensive comparisons of 1H and 13C NMR chem. shift values in the furanone cores a, b, and c provide plausible support for a reassessment of the furanone nuclei of the title compounds from b to c. Total syntheses via enantiomerically pure lactic esters were based on the Seebach-Frater “self-reproduction of stereocenters” methodol. Attachment of the hexadienyl side-chain in a trans,trans-selective manner was achieved by addition of the Seebach-Frater enolate to trans-hex-4-en-1-al rather than to trans-hex-3-en-1-al. The type-c furanone cores of the synthetic materials were reached by single or double acylation of model γ-hydroxy-β-oxo ester I and its hexadiene-containing counterpart II. Our syntheses confirmed the novel connectivities in six compounds In addition, they required revision of the configuration of a quaternary carbon atom in five cases. Moreover, they allowed elucidation of the configurations of four previously unassigned stereocenters. Hindsight analyses of why the furanone cores of the title compounds had been misinterpreted as a and/or b instead of c are given. Why the stereocenters in the heterocycles had been incorrectly configured, on the bases (a) of relay studies in the 1960s, and (b) of a 1984 total synthesis of gregatin B, is also discussed. The experimental process involved the reaction of (R)-Methyl 3-hydroxybutanoate(cas: 3976-69-0).Category: esters-buliding-blocks

The Article related to synthesis lactic ester gregatin aspertetronin, mol structure revision gregatin graminin aspertetronin penicilliol huaspenone cyclogregatin, nmr chem shift mol structure revision furanone derivative, seebach frater self reproduction stereocenters methodol synthesis gregatin aspertetronin, hexadienyl side chain addition trans selective manner and other aspects.Category: esters-buliding-blocks

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics